Bausch Health Companies (BHC) Acquisitions (2009 - 2019)
Bausch Health Companies' (BHC) quarterly Acquisitions came in at $180.0 million in Q1 2019, up 3700.0% year-over-year from $4.7 million in Q1 2018, and up 1900.0% quarter-over-quarter from -$10.0 million in Q4 2018.
Analysis
Bausch Health Companies (BHC) Acquisitions (2009 - 2019) Analysis & Trends
Bausch Health Companies has disclosed Acquisitions across 10 years of filings, most recently posting $180.0 million for Q1 2019.
- In Q1 2019, Acquisitions rose 3700.0% year-over-year to $180.0 million; the TTM figure through Dec 2019 stood at $180.0 million (up 3700.0% YoY), while the FY2023 annual figure was $1.9 billion, up 4100.0% from the prior year.
- Acquisitions came in at $180.0 million for Q1 2019 at Bausch Health Companies, up from -$10.0 million in the prior quarter.
- In the past five years, Acquisitions ranged from a high of $13.1 billion in Q2 2015 to a low of -$10.0 million in Q4 2018.
- Average Acquisitions over 4 years is $1.4 billion, with a median of $19.0 million recorded in 2016.
- Year-over-year, Acquisitions surged 19151.32% in 2015 and tumbled 99.87% in 2016.
- Over 4 years, Acquisitions stood at $1.5 billion in 2015, then plunged by 99.66% to $5.0 million in 2016, then plunged by 300.0% to -$10.0 million in 2018, then surged by 1900.0% to $180.0 million in 2019.
- Per Business Quant data, the three most recent Acquisitions figures were $180.0 million in Q1 2019, -$10.0 million in Q4 2018, and $10.0 million in Q3 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | -2.32 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2019 | 180.00 Mn |
| Dec 31, 2018 | -10.00 Mn |
| Sep 30, 2018 | 10.00 Mn |
| Mar 31, 2018 | -5.00 Mn |
| Sep 30, 2016 | 5.00 Mn |
| Jun 30, 2016 | 17.00 Mn |
| Mar 31, 2016 | 19.00 Mn |
| Dec 31, 2015 | 1.46 Bn |
| Sep 30, 2015 | 115.80 Mn |
| Jun 30, 2015 | 13.09 Bn |
| Mar 31, 2015 | 795.00 Mn |
| Dec 31, 2014 | 120.90 Mn |
| Sep 30, 2014 | 606.80 Mn |
| Jun 30, 2014 | 68.00 Mn |
| Mar 31, 2014 | 306.30 Mn |
| Dec 31, 2013 | 63.10 Mn |
| Sep 30, 2013 | 4.44 Bn |
| Jun 30, 2013 | 513.40 Mn |
| Mar 31, 2013 | 237.60 Mn |
| Dec 31, 2012 | 2.51 Bn |